EUR 309.30 For Business Accounts Only

Pharmaceuticals in Germany

Summary
Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts

Synopsis
Essential resource for top-line data and analysis covering the Germany pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buys

- What was the size of the Germany pharmaceuticals market by value in 2016?
- What will be the size of the Germany pharmaceuticals market in 2021?
- What factors are affecting the strength of competition in the Germany pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Germany's pharmaceuticals market?

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.
- The German pharmaceuticals market had total revenues of $35.2bn in 2016, representing a compound annual growth rate (CAGR) of 5% between 2012 and 2016.
- The German market largely consists of companies which are relatively small compared to the large multinational giants which dominate many markets around the world. There are approximately 669 registered pharmaceutical companies in Germany; around 93% of those producing medicine still employ fewer than 500 staff.
- Germany has a mature market with high healthcare expenditure and domestic pharmaceutical production but it is the cost-saving government policies that remain the largest barrier to future growth.